The Importance of President Obama’s Executive Order on Embryonic Stem Cells. BIO is a strong advocate for federal funding of stem cell research and welcomes President Obama’s . Biotech Research — Blogs, Pictures, and more on
BSR Core Research The Biotech Stock Research, LLC team has 26 dev-stage biotech companies under formal coverage. We are independent, with no bankers, no trading desk, we don’t . Biotech Stock Research – Independent research, plain English
Biotech ResearchBioTech Research: Better Health Through Technology. BioTech Research is the leader in health, diet, fitness, and therapeutic equipment designed to help you live a healthy and .
W elcome to BioTech! Our goal is to enrich the public’s knowledge of biology and chemistry. We aim to serve everyone from high school students to professional researchers. BioTech
Sens. Charles Schumer (D-N.Y.) and Susan Collins (R-Maine) on Thursday introduced legislation (S 726) that would allow FDA to approve generic versions of biotechnology drugs after a five-year period of brand-name patent exclusivity, the New York Times reports. biotech research
Chiltern International Limited (Chiltern), a global Clinical Research Organization (CRO) that provides clinical development and staffing services in Europe, the Americas and India and its Asian partner EPS International Co. Ltd. (EPS INTERNATIONAL), a wholly owned subsidiary of EPS Co. Ltd., a leading provider of clinical development services in the Asian region, have jointly organized a seminar in Tokyo, Japan on 24th April 2009 to coincide with the 3rd anniversary of EPS International. biotech research
Zydus Pharmaceuticals announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Tablets USP, 25mg, 50mg, 100mg, and 200mg. This product is available for immediate shipment. Topiramate tablets are indicated as an initial monotherapy in patients 10 years old or older with partial onset or primary generalized tonic-clonic seizures. biotech research
The region’s largest biotechnology association today warned that a bill under consideration by the Vermont Legislature will create the most restrictive and onerous regulatory environments for biotechnology growth and development not only in New England, but in the entire nation. Senate Bill 48, an Act Relating to the Marketing of Prescribed Products, is the focus of a presentation today at the State House by Senate President Peter Shumlin. biotech research
